SIRT1 and myeloid sarcoma: As plasma levels of SIRT1 were found to be increased in MS patients when compared with non-neurological disease controls, it is also postulated that soluble/circulating SIRT1 is an adaptive response during MS and it may play an important role in disease pathogenesis [85].